Drug Type Oncolytic virus |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization GeneMedicineStartup |
Active Organization GeneMedicineStartup |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | KR | GeneMedicineStartup | 20 Feb 2024 |
Colorectal Cancer | Phase 2 | KR | GeneMedicineStartup | 20 Feb 2024 |
Head and Neck Neoplasms | Phase 2 | KR | GeneMedicineStartup | 20 Feb 2024 |
Locally Advanced Malignant Solid Neoplasm | Phase 2 | KR | GeneMedicineStartup | 20 Feb 2024 |
Melanoma | Phase 2 | KR | GeneMedicineStartup | 20 Feb 2024 |
Renal Cell Carcinoma | Phase 2 | KR | GeneMedicineStartup | 20 Feb 2024 |
Uterine Cervical Cancer | Phase 2 | KR | GeneMedicineStartup | 20 Feb 2024 |